Product Information

ZOLMITRIPTAN 2.5 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.9324 per EA under NDC 62332046206. Its NADAC has been published 126 times since Jun 19, 2024.

FDA first approved this application on Sep 30, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ZOLMITRIPTAN 2.5 MG TABLET

Zolmitriptan
$0.9324per EA

Strength

2.5 mg/1

NDC

62332046206

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ZOLMITRIPTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA204232

FDA Approved

9/30/2015

TE Code

AB

On Market Since

1/10/2024

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for ZOLMITRIPTAN 2.5 MG TABLET has been published 126 times since Jun 19, 2024, and over the history we have for it it has declined 16.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9324 per EA
All-time high$1.4626 (Jul 16, 2025)
All-time low$0.8451 (Jul 17, 2024)
52-week high$1.1116
52-week low$0.9324
Median price$1.1116
Average price$1.1639
Largest weekly change+63.7% (Aug 21, 2024)
Weeks tracked126
Tracking sinceJun 19, 2024

Price History

1W

0.0%

1M

-8.8%

3M

-11.9%

6M

-10.9%

1Y

-20.4%

3Y

N/A

5Y

N/A

All

-16.0%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ZOLMITRIPTAN 2.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 2.5 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.9324 per EA (NDC 62332046206), effective Nov 11, 2026.

How has the price of ZOLMITRIPTAN 2.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ZOLMITRIPTAN 2.5 MG TABLET has declined 16.0%. It has been tracked across 126 weekly CMS publications since Jun 19, 2024.

What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 2.5 MG TABLET?

Since Jun 19, 2024, the NADAC for ZOLMITRIPTAN 2.5 MG TABLET has ranged from a low of $0.8451 (Jul 17, 2024) to a high of $1.4626 (Jul 16, 2025), with a median of $1.1116 per EA.

Are there cheaper alternatives to ZOLMITRIPTAN 2.5 MG TABLET?

10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ZOLMITRIPTAN 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ZOLMITRIPTAN 2.5 MG TABLET?

ZOLMITRIPTAN 2.5 MG TABLET (NDC 62332046206) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.